40 results
Page 2 of 2
8-K
EX-99.1
fty hl9bipeklw7isx
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
8-K
d417n344ql3ijmggz
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
yewem5r76
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-99.1
j23rb36 h7j8hqyk8oc
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
krzmr2pcwveieyj
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:11am
8-K
EX-99.2
b427g9oj4itg2od9
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
10-K
EX-10.16
0egwwt gbhhop
13 Mar 17
Annual report
12:00am
10-K
p6zbr
13 Mar 17
Annual report
12:00am
20-F
no8npq
13 Oct 15
Annual report (foreign)
12:00am
6-K
EX-99.3
lr4oyo6pff4xdcpol
9 Oct 15
Adaptimmune announces New Research and Development Facility in Oxfordshire
12:00am
DRS
50sp27dcu2
5 Feb 15
Draft registration statement
12:00am